Navigation Links
Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes'
Date:2/19/2008

litigations is to highlight the fact that often, older tried and tested medications are ignored in the face of new and untested medications that have been heavily promoted by the drug manufacturers to the detriment of the unknowing public." Bern continued, "We are suing for tens of millions of dollars on the Randone family's behalf because of Bayer's reckless conduct -- not only with regard to its marketing of Trasylol but also but for the public health debacles arising from its products Baycol and Factor 9. Baycol is known to have caused more than 30 deaths, and thousands of hemophiliacs using blood clotting medication Factor 9 developed HIV and AIDs from tainted and untested Factor 9."

Joseph Randone was administered Bayer's drug Trasylol on January 16, 2006, during the course of what should have been a Coronary Artery Bypass Graft surgery performed at Stony University Hospital, Stony Brook, New York. As a result of the use of the drug, Mr. Randone began experiencing renal insufficiency soon after heart surgery, and subsequently went into renal failure, which led to Mr. Randone suffering from hypotension (low blood pressure), wound breakdown and infection, including wounds of the abdomen and chest; he needed artificial feeding through indwelling tubes in the stomach, required further surgeries including revisions of pacemaker placement, cholecystectomy, and revision of gastrostomy tubes. As his rocky post-surgery period continued, Mr. Randone suffered gastrocutaneous fistula, a breakdown of the skin and tissue surrounding the stomach and needed a feeding tube surgically implanted. Ultimately, Mr. Randone underwent amputation of both legs and amputation of his left hand due to gangrene. The combination of all of these procedures, wounds and infections and renal failure ultimately led to his untimely death on August 8, 2006. Prior to his initial bypass surgery, Mr. Randone had no knowledge that the Trasylol that would be administered during surgery might caus
'/>"/>

SOURCE Napoli Bern & Associates, LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
2. Trasylol Pulled From Worldwide Market
3. Bayer Temporarily Suspends Global Trasylol(R) Marketing
4. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
5. CryoCath Provides Update on Patent Infringement Lawsuit
6. More Women File Lawsuits Against Dallas Presbyterian Hospital in Eating Disorders Fraud Case
7. Abbey Spanier Rodd & Abrams, LLP Files Class Action Lawsuit on Behalf of Purchasers of American Dental Partners, Inc. Securities
8. Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit
9. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
10. The Willie Gary Law Firm Files $1 Billion Lawsuit Against Durham County LME, Wake County LME, Five County LME, Mecklenberg County LME and Value Options, Inc. for Negligent and Intentional Misconduct Against Mental Health Agency
11. Hollywood Presbyterian Medical Center Responds to ACLU Lawsuit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...wswire-USNewswire/ -- March of Dimes hosted the Fo...gnize prominent individuals who are celebrating th...for March of Dimes commitment to improve the healt...er Prematurity Awareness Month campaign, celebriti... for preemies! ,, (Photo: http://www.newscom....
(Date:11/7/2009)...re-USNewswire/ -- Speaker Nancy Pelosi spoke on t...Affordable Health Care for America Act. The House...w are the Speaker,s remarks. ,, "Madam Speaker... our nation and for American families. For nearly...hilosophy -- as far back as Teddy Roosevelt -- hav...
(Date:11/7/2009)...ewswire/ -- The American Medical Association (AMA)...at the Family Violence Prevention Fund, with the C...i-annual policy-making meeting. The Citation for ... House of Delegates bestows on a non-physician. ...h/20081209/AMALOGO ) ,, "Ms. James has worked...
(Date:11/7/2009)... Calling this a "defining moment" for the American...ames Rohack, M.D., today addressed medical student... specialty societies at the opening of the AMA,s s...tem reform will top the agenda. ,, (Logo: htt... ) ,, "Over the next 72 hours, this AMA House ...
(Date:11/7/2009)...USNewswire/ -- With the final House vote on health...ding the entire bill hostage to further their anti...go far beyond the status quo restrictions on abort...ill. In an outrageous amendment, which is expecte...ice Democrats are demanding explicit and unequivoc...
Breaking Medicine News(10 mins):Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...pen in 2011 and bring 600 new jobs to the region ,...a,s largest retail pharmacy, announced today that ...oot distribution center in Chemung County, New Yor... the inventory and fulfillment needs of approximat...
...t to begin after markets close at 2:00 p.m. PT (5:...orporation (Nasdaq: MASI ), the inventor of Puls...erfusion pulse oximetry, today announced it will r... , A conference call to review the results will b...
...Roster, Fielding Five Teams to Spread Personal Mes...Living with Type 1 and Type 2 Diabetes , , BRIDGE... today its long-acting insulin Lantus(R) (insulin ...Team Type 1, a team of amateur and professional at...
... Palomar Medical Technologies, Inc. (Nasdaq: PMT...ased systems for cosmetic treatments, today announ...ear ended December 31, 2008. Revenues for the qua...unded development revenues, and $1.25 million were...
...e-FirstCall/ - Transition Therapeutics Inc. ("Tran... ) today announced the completion of patient enrol...gue, TT-223, in patients with type 2 diabetes. The...nts for 12 weeks with a 6-month follow-up. Approxi...
... years, Electronic Health Records (EHRs) have been... improving patient care and controlling costs. Ho... expected due to general resistance related to imp...rison to basic usability and productivity concerns...
Other Medicine News:Health News:CVS/pharmacy Announces Plans for New Distribution Center in Southern New York 2Health News:Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009 2Health News:Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009 3Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 2Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 3Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 4Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 5Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 6Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 3Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 4Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 6Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 8Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 9Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 10Health News:Transition Therapeutics Announces Completion of Patient Enrolment of Phase 2 Study of TT-223 in Type 2 Diabetes Patients 2Health News:How to Select an Electronic Health Record System That Healthcare Professionals Can Use 2
(Date:11/6/2009)...6 America,s Specialty M...up of mid-market and smaller innovator pharmaceuti... 3962, the "Affordable Health Care for America Act...hese smaller companies fear that the cumulative ef...der their efforts to bring new medicines to market...
(Date:11/6/2009)... NuVasive, Inc. (Nasdaq:...loping products for minimally disruptive surgical ...intment of Michael J. Lambert as Executive Vice Pr...ember 9, 2009. The Company also announced several...ichael will be an excellent complement to the NuVa...
(Date:11/6/2009)... Nov. 6 Philips Respironics applau...and Prevention (CDC) to raise awareness about an i...fficiency. The CDC,s release of the first-ever gov...s in sleeplessness is a milestone in quantifying t...-time educator, industry leader and sleep therapy ...
Breaking Medicine Technology:Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 1Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 2Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 3Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 4Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 5Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 6Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 7Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 8Hanger Orthopedic Group Inc Reports 240 31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 53000 9Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 1Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 2Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 3Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 4Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 5Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 6Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 7Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 8Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 9Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 10Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 11Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 12Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 13Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 14Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 15Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 16Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 17Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 18Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 19Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 20Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 21Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 22Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 23Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 24Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 25Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 26DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
..., N.J., Oct. 30 Leading researchers,will present ...hepatitis,products, including PEGINTRON(TM) (pegin...combination therapy, a current standard of care in... American Association for the,Study of Liver Disea...mong these are several studies discussing the pred...
...card Provides Hospital-Wide View of MRSA Infection...al provider of products and services that improve ...announced a new service to help,hospitals combat m...infections that are responsible for an estimated 9...s annually in the U.S.(1) Cardinal Health is depl...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 7Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 2Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 3
Gellhorn Pessary
Ring Pessary
Pyramis
...female urinary stress incontinence (SUI) with a mi...ic (BioArcTM SP) or a transobturator (BioArcTM TO)...em combining synthetic and biologic materials. It ...BioArc utilizes a polypropylene mesh for fixation ...
Medicine Products: